Innexus to showcase OptiPEA at Vitafoods Europe

The safe and reliable pain relief solution

With demand for nutraceutical pain relief solutions on the rise, Innexus Nutraceuticals (booth J92) is to showcase the first source of PEA produced entirely in Europe for use as an active ingredient in dietary supplements.

PEA (palmitoylethanolamide) is a naturally occurring bioactive lipid that offers a genuine nutraceutical alternative to problematic pain relief drugs.

OptiPEA, which will be on show at Vitafoods Europe 2018, is the leading PEA raw material available. It is sourced sustainably from RSPO-certified palmitic acid and manufactured entirely in Europe using a patented production process.

With all other PEA manufactured in Asia, OptiPEA is the only PEA ingredient to be manufactured entirely in Europe.

It is reliable, safe and ethically sourced. Samuel Zonneveld, CEO at Netherlands-based Innexus, said: “Because of the difficulties in treating chronic pain, it is not uncommon for sufferers to take matters into their own hands. At the same time, the problems that result from sustained use of opioids — both pharmaceutical pain-killers and non-prescription drugs — are becoming ever clearer.”

He added: “Unlike most of these, PEA doesn’t have any negative side-effects. Yielding consistently positive results in replicable research since its discovery in 1952, its efficacy and safety have been documented in more than 658 scientific articles. PEA represents a natural and effective alternative to these drugs, and one that is suitable for long-term use.”

“Today’s consumers are well-informed; they demand and deserve transparency. OptiPEA offers full, transparent documentation to dietary supplement companies who can benefit from the appeal of a branded, quality ingredient for consumers,” Zonneveld added.

Companies